First and second-line therapy of high-risk MDS patients

被引：0
|
作者：
Platzbecker, U. [1 ]
机构：
[1] Uniklin Dresden, Med Klin 1, Dresden, Germany
来源：
ONKOLOGIE | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [11] Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients
    Suzuki, Kazuhito
    Gunji, Tadahiro
    Nagao, Riku
    Kawashima, Masaharu
    Uryu, Hideki
    Momoki, Mamiko
    Ishii, Hiroto
    Fukushima, Ryoko
    Katori, Mitsuji
    Yokoyama, Hiroki
    Katsube, Atsushi
    Saito, Takeshi
    Nishiwaki, Kaichi
    Yano, Shingo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025,
  • [12] Second-Line Low-Dose Cytarabine after First-Line Treatment with 5-Azacitidine in Elderly Patients with AML or High-Risk MDS Ineligible for Intensive Chemotherapy. A Retrospective Single Center Analysis
    Jakob, Christian
    Gunther, Benjamin
    Dittberner, Katharina
    Boger, Leonard
    Bleienheuft, Philipp
    Breywisch, Frank
    Rothmann, Frank
    Peinert, Stefan
    Maschmeyer, Georg
    BLOOD, 2015, 126 (23)
  • [13] First- and second-line therapy of metastatic colorectal cancer
    Terstriep, Shelby
    Grothey, Axel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 921 - 930
  • [14] Docetaxel in the first- and second-line therapy of gastric cancer
    Vanhoefer, U
    ONKOLOGIE, 2000, 23 : 40 - 42
  • [15] ICE INDUCTION PLUS AZA MAINTENANCE AS A FIRST LINE THERAPY IN HIGH RISK MDS PATIENTS: CETLAM MDS-09 RESULTS
    Bargay, J.
    Xicoy, B.
    Brunet, S.
    Tormo, M.
    Pedro, C.
    Talarn, M.
    Coll, R.
    Nomdedeu, M.
    Marti, J.
    Borras, J.
    Ortin, X.
    Valcarcel, D.
    Sampol, A.
    Marco, V.
    Ramila, E.
    Sierra, J.
    Ribera, J.
    HAEMATOLOGICA, 2014, 99 : 614 - 614
  • [16] Resistance in Pediatric Patients Experiencing Virologic Failure With First-line and Second-line Antiretroviral Therapy
    Orrell, Catherine
    Levison, Julie
    Ciaranello, Andrea
    Bekker, Linda-Gail
    Kuritzkes, Daniel R.
    Freedberg, Kenneth A.
    Wood, Robin
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (06) : 644 - 647
  • [17] Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa
    Onoya, Dorina
    Nattey, Cornelius
    Budgell, Eric
    van den Berg, Liudmyla
    Maskew, Mhairi
    Evans, Denise
    Hirasen, Kamban
    Long, Lawrence C.
    Fox, Matthew P.
    AIDS PATIENT CARE AND STDS, 2017, 31 (05) : 205 - 212
  • [18] Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
    Meloni, Seema T.
    Onwuamah, Chika K.
    Agbaji, Oche
    Chaplin, Beth
    Olaleye, David O.
    Audu, Rosemary
    Samuels, Jay
    Ezechi, Oliver
    Imade, Godwin
    Musa, Adesola Z.
    Odaibo, Georgina
    Okpokwu, Jonathan
    Rawizza, Holly
    Mu'azu, Muhammad A.
    Dalhatu, Ibrahim
    Ahmed, Mukhtar
    Okonkwo, Prosper
    Raizes, Elliot
    Ujah, Innocent A. O.
    Yang, Chunfu
    Idigbe, Emmanuel O.
    Kanki, Phyllis J.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (04):
  • [19] First-line and second-line antiretroviral therapy - Author's reply
    Carr, A
    LANCET, 2004, 364 (9431): : 330 - 330
  • [20] The Transition From First-Line to Second-Line Therapy in Multiple Sclerosis
    Jan Dörr
    Friedemann Paul
    Current Treatment Options in Neurology, 2015, 17
12345